AI summary by TwinMind

Supplements for Longevity & Their Efficacy | Dr. Peter Attia

Andrew Huberman

2h 30m 41s

Framework for Longevity Approaches

  • Four categories of longevity interventions discussed
    • Dos/don'ts: exercise (Zone 2 cardio, resistance training), nutrition, genetics
    • Calories/glucose/insulin targeting mTOR pathway
    • Targeting specific cellular pathways (NAD pathway focus)
    • Kitchen sink approach (Brian Johnson-style comprehensive interventions)
  • Peter's alternative framework: behavioral essentials vs. exogenous molecules
    • Category 1: Essential behaviors (eating, sleeping, moving) - choice is how to do them correctly
    • Category 2: Molecules targeting disease processes (Metformin, SGLT2 inhibitors, statins)
    • Category 3: Geroprotective molecules targeting aging hallmarks (rapamycin)

Peter's Current Supplement Regimen

  • Disease-specific: PCSK9 inhibitor, bempedoic acid, SGLT2 inhibitor
  • Geroprotective: Rapamycin 8mg once weekly (with breaks due to aphthous ulcers)
  • Other supplements: EPA/DHA fish oil, curcumin, vitamin D (5,000 IU), methyl folate, methyl B12
  • Sleep support: magnesium L-threonate, ashwagandha
  • Magnesium in three forms: L-threonate, slow-release chloride, oxide
  • Probiotics: Pendulum (glucose control, polyphenol, Akkermansia)
  • Daily: Element electrolytes, creatine monohydrate 5g, AG1

Andrew's Supplement Regimen

  • Core daily: AG1 (1-2 servings), quality fish oil (>1g EPA), vitamin D3 (5,000 IU)
  • Testosterone support: Tongkat Ali (lowers SHBG)
  • Energy/cognitive: Green tea capsules, yerba mate, creatine monohydrate 10g
  • NAD pathway: NMN powder (1,500mg sublingual), occasionally NR
  • Sleep support: magnesium threonate, apigenin 50mg, theanine, occasionally inositol 900mg
  • Other: methyl B12, Element electrolytes, whey protein

Rapamycin Deep Dive

  • Only two interventions extend life across species: caloric restriction and rapamycin
  • Peter's dosing: 8mg weekly with breaks due to aphthous ulcers (10% experience this)
  • Mechanism: mTOR inhibition, autophagy stimulation, senescent cell suppression
  • Upcoming data: Dog aging study (2026), University of San Antonio mammal trials
  • Key human study: 2014 everolimus study showed enhanced immune response to flu vaccine in 65+ year olds
  • Dosing matters: daily suppresses immunity, weekly pulsing enhances it

Sirtuins and NAD Pathway History

  • Original discovery: Matt Kaeberlein's 1999 yeast study showing SIR2 overexpression extends lifespan
  • Key finding: Caloric restriction and sirtuin activation are parallel, not connected pathways
  • 2004 study proved additivity: CR + sirtuin overexpression = longer lifespan than either alone
  • Only one mammalian success: 2012 transgenic mouse overexpressing SIRT6 (10-15% male lifespan extension)
  • Resveratrol failure: ITP testing showed no lifespan extension despite theoretical sirtuin activation

NAD Biology and Metabolism

  • Present in essentially every cell except possibly red blood cells
  • 99% function: co-factor for 500-600 electron shuttle pathways (NAD ⇌ NADH)
  • 1% function: substrate consumption by sirtuins for DNA repair
  • Tight regulation like glucose and pH - narrow functional band essential for survival
  • Age-related decline: skin 60% reduction, brain/blood ~20% reduction over lifetime
  • 2015 study: NAD levels decline but NADH levels increase with age
  • Real issue: reduced redox potential, not absolute NAD deficiency

NAD Supplementation Options and Bioavailability

  • Direct NAD: IV infusion only (oral breaks down in gut)
    • Andrew's experience: 10 minutes chest pressure, nausea, cramping, then feeling good
    • Cost: $300-1,000 per infusion
  • NMN (nicotinamide mononucleotide): Cannot cross cell membrane directly due to phosphate group
    • Sublingual or oral administration, phosphate cleaved in gut
    • Andrew takes 1,500mg sublingual, observes hair/nail growth acceleration
  • NR (nicotinamide riboside): Crosses cell membrane directly
    • FDA GRAS status, commercially available
    • Claims 25% more effective than NMN milligram-for-milligram
  • Mouse studies require 500-1,000mg/kg (50-100g for 100kg human) - economically unfeasible

Clinical Evidence for NAD Supplementation

ITP (Interventions Testing Program) Results

  • Gold standard for longevity molecule testing in mice
  • NR tested at high doses: NO lifespan extension, NO health span improvement
  • Contrast with successful molecules: rapamycin, canagliflozin, acarbose, 17-alpha-estradiol

Human Studies - Mixed Results

  • Fatty liver study: No primary endpoint improvement
    • Sub-analysis: modest hepatic fat reduction in <27% fat group (statistical not clinical significance)
  • Glucose disposal study: minimal improvement in insulin-mediated glucose uptake
    • Statistically significant but clinically irrelevant magnitude

Potential Skin Cancer Benefit

  • One study showed 60-80% reduction in basal and squamous cell carcinomas
  • No effect on melanoma (the deadly skin cancer)
  • Mechanistically interesting: skin shows greatest age-related NAD decline
  • Requires replication before drawing conclusions

FDA Regulatory Status

  • NMN: FDA ruled should not be sold as supplement due to clinical trial designation
    • Many companies continue selling despite ruling
    • Regulatory limbo similar to N-acetyl cysteine situation
  • NR: GRAS status, freely available as supplement

Commercial Considerations

  • Peter views NR vs NMN debate as purely commercial positioning
  • No meaningful scientific difference between the two
  • Cost considerations drive choice more than efficacy differences
  • Mouse-equivalent doses would cost ~$300/day in humans

Biological Age Testing Critique

  • Peter strongly skeptical of biological age tests
  • Key question: Do they predict remaining lifespan better than chronological age?
  • Issues: High biological noise, lack of standardization, false precision
  • Movement age test gave Peter result of 22 years old at age 51 - clearly unrealistic
  • Most tests haven't been validated against actual longevity outcomes

Energy and Aging Discussion

  • Spontaneous energy outbursts decline dramatically from childhood to adulthood
  • Unclear why energy decreases with age despite NAD supplementation
  • Exercise timing matters: morning workouts (before 9am) provide all-day energy boost
  • Late morning/afternoon workouts can be depleting for remainder of day
  • Hypothesis: circadian temperature regulation interaction with exercise-induced temperature changes

Radiation Exposure Context

  • Annual NRC recommendation: <50 millisieverts radiation exposure
  • Sea level ambient: 1 mSv/year (2% of allowance)
  • Colorado altitude: 2 mSv/year
  • CT angiogram: 3-15 mSv depending on facility
  • Nuclear plant workers: ~500 mSv/year with no increased cancer risk
  • Airport scanners and flights: minimal concern based on pilot data

Critical Life Phases for Health Investment

  • Ages 50-70 identified as crucial window for health span/lifespan optimization
  • Aging effects become more apparent: reduced resilience, longer recovery times
  • Goal: build maximum physiologic reserve while still possible
  • Muscle mass addition becomes very difficult after mid-70s
  • Power loss most dramatic (50% vertical jump decline from teens), followed by strength, then muscle mass
  • Injury recovery ratios worsen: 2:1 or 3:1 inactivity to activity needed for recovery

Final Recommendations and Perspectives

Supplement Hierarchy (Titanic Analogy)

  • Ship's direction (exercise, sleep, nutrition, emotional health) = primary determinants
  • Supplement choices = "lobster vs steak" - secondary considerations
  • All discussed supplements matter far less than foundational behaviors

NAD Pathway Verdict

  • Peter: Does not take NR/NMN/NAD, sees no compelling evidence for longevity benefit
  • Andrew: Takes NMN/NR but not for longevity - observes energy/hair growth effects
  • Both agree: no evidence for lifespan extension, minimal evidence for health span benefits
  • Potential exception: skin cancer prevention (requires replication)

Investment Philosophy

  • Peter's conviction test: "Show me your portfolio, not your theories"
  • Demonstrates conviction through actions: rigorous exercise, sleep optimization, selective supplementation
  • Willing to change position based on new data
  • Current assessment: NAD pathway supplementation not justified for longevity goals

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome